Search

COVID-19 is a viral infection transmitted through the respiratory system, caused by Coronavirus type 2 usually get excess to the body through Flügge microdroplet of an infected person to a healthy one with air although direct contact and aerosol may be another route for transmission. This is a prospective study of 500 patients (63% women) conducted in a medical city in Baghdad. In a study patients' collection started in Aug 2020 for six weeks. They followed for at least six months after they recovered from COVID-19. Among 500 patients included 53.4% were male (out of those 118 were complain of severe headaches 23.6%), while females comprise about 46.6% of total patients of that 13% had severe headaches. The highest age group with severe headaches was (60-65) years coming next (51-55) years. group A had a partial response to drugs used although more than 60% respond to a combination of Ibuprofen and Acetaminophen, while in group B good control of Headache was achieved (80%) when adding Phenytoin to treatment protocol during and after the acute stage of the disease. There is controversy about the treatment of headaches caused by COVID-19 but for sure, Acetomenaphin combined with NSADI drugs is the best and safe choice. In refractory cases, antiepileptic drugs like phenytoin are added to achieve freedom of pain and for a long-term period. [ABSTRACT FROM AUTHOR]

Copyright of Revista Latinoamericana de Hipertension is the property of Revista Latinoamericana de Hipertension and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: Any luminal closed space that is lined by either membranous or cellular sheathe and containing air, fluid, solid or semisolid material is called Cyst. In the Orbit this cyst can be resulted from either ductal obstruction, developmental, or parasitic infestation, Objective: Assessment of the distribution of Orbital Hydatid cyst according to age, gender, site, clinical features. Method: A retrospective study conducted for the period from 2010-2020, during which 632 patients with orbital cyst attend the Orbital clinic in Medical city in Baghdad. This clinic receives most of orbital cases from all governorate of Iraq. Results: Ten patients out of 632 cases had Orbital Hydatid cyst (1.58%). The age was ranging from 3-15 years with a mean of (8.6±4.1 years). Three cases were female, with a male to female ratio 2:1. Orbital Hydatid cyst affecting the right side in 6 patients, while the left orbit was involved in 4 patients. No bilateral Orbital Hydatid cyst. With respect to the site of the lesion inside the orbit, 3 of them were superiomedial, while seven were superiolateral, no inferior lesion found in this study. The most common presenting features was painless proptosis (90%), followed by chemosis (60%), and conjunctival edema 30%. Conclusion: Hydatid disease of the Orbit usually it is the primary lesion, which is rare disease. Most of the cases are unilateral, located superiorly (medial or lateral) retro bulbar in location whether extra or intraconal. No sex dominance found although commonly affect children and teens. The most common clinical presentation is painless proptosis. When suspected, patients better to be evaluated by either computed tomography or by magnetic resonance imaging. [ABSTRACT FROM AUTHOR]